Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022
There are totally 93 fluorine aromatic scaffolds containing drugs approved by U.S. Food and Drug Administration from 2002 to 2022. The proportion of drugs containing fluorinated aromatic skeleton in approved drugs is increasing in recent ten years, which indicates the unique and important attributes...
Main Authors: | Pengfei Xu, Lijun Zhu, Desheng Zhang, Zilong Li, Raoling Ge, Qiang Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Results in Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715624001425 |
Similar Items
-
FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
by: Carla Rizzo, et al.
Published: (2023-04-01) -
FDA Approvals of Biologics in 2022
by: Alexander C. Martins, et al.
Published: (2023-05-01) -
Asymmetric Synthesis of US-FDA Approved Drugs over Five Years (2016–2020): A Recapitulation of Chirality
by: Rekha Tamatam, et al.
Published: (2023-02-01) -
The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.
by: Timothée Olivier, et al.
Published: (2022-04-01) -
New Halogen-Containing Drugs Approved by FDA in 2021: An Overview on Their Syntheses and Pharmaceutical Use
by: Davide Benedetto Tiz, et al.
Published: (2022-03-01)